L-alanine dehydrogenase from Mycobacterium tuberculosis catalyzes the NADH dependent reversible conversion of pyruvate and ammonia to L-alanine. Expression of the gene coding for this enzyme is up-regulated in the persistent phase of the organism, and alanine dehydrogenase is therefore a potential target for pathogen control by antibacterial compounds.
Introduction

In view of the annual death toll of approximately 2 million individuals due to infection by
Mycobacterium tuberculosis the emergence of multi-drug resistant and extensively drug resistant strains of Mycobacterium tuberculosis poses a major threat to human health worldwide (WHO homepage: http://www.who.int). Treatment of this disease is further complicated by the ability of M. tuberculosis to persist in the lungs of infected individuals for decades by switching to a dormant or latent phase 1 , which also induces tolerance to current antibiotics 2, 3 . About one-third of the world's population is infected with persistent mycobacteria providing an enormous potential reservoir for further spread of this disease.
Dormancy has been associated with non-replicating or very slow growth of M. tuberculosis that resides in granulomas, a heterogeneous assembly of macrophages, in the lungs of infected individuals. It is generally assumed that the microenvironment in the granulomas is characterized by hypoxia, nutrient starvation and reactive oxygen and nitrogen species [4] [5] [6] .
Several experimental in vitro models for the dormant phase of the bacilli have been developed, albeit their relevance to human latent infection is still a matter of debate. A widely used in vitro approach to mimic dormancy is based on culture of M. tuberculosis under microaerophilic/anaerobic conditions 7 . Other models of dormancy utilize nutrient starvation 8 or treatment by nitric oxide 9 . Drug-induced persistence has been studied in vitro using stationary M. tuberculosis grown under microaerophilic conditions treated with rifampicin or in vivo by pyrazinamide-induced persistent bacteria in mice 10 . These model systems have been employed to study the metabolic state of the bacteria in the dormant phase. Comparison of gene-expression profiles and proteome analyses of active versus non-replicating bacteria have identified a number of genes that are up-regulated in persistent M. tuberculosis 8, [11] [12] [13] [14] [15] [16] .
One of these genes, Rv2780, found to be over-expressed under hypoxic 14, 15 and nutrient starvation 8 regimes encodes L-alanine dehydrogenase (L-AlaDH). Increased levels of this enzyme have been linked to the generation of alanine for peptidoglycan biosynthesis 15, 17 and the maintenance of the NAD+ pool under conditions when the terminal electron acceptor oxygen becomes limiting 8, 15, 18 .
L-AlaDH catalyzes the NADH-dependent conversion of pyruvate and ammonia to L-alanine ( Figure 1 ), and is involved in microbial carbon and nitrogen metabolism. The mycobacterial enzyme is secreted into the culture medium, and is identical to the 40 kDa antigen that has been identified in culture filtrates of M. tuberculosis 19 . In solution the enzyme forms a hexamer of six identical subunits (predicted molecular mass 38988 Da per subunit) 20 , as observed for most L-alanine dehydrogenases from other species, for instance Phormidium lapideum 21 , Streptomyces phaeochromogenes 22 and Bacillus subtilis 23 . The hexameric molecule of L-AlaDH from Phormidium lapideum shows 32 point group symmetry, and is best described as a trimer of dimers 24 .
Kinetic and mechanistic studies of L-alanine dehydrogenases from several species 17, [25] [26] [27] [28] showed that the enzyme follows a predominantly ordered mechanism, with NAD+ and NADH binding occurring first in the oxidative deamination and reductive amination direction, respectively. The enzymatic mechanism most likely proceeds through imino acid and carbinolamine intermediates 27 . Crystal structures of binary complexes of L-AlaDH from
Phormidium lapideum have identified the binding sites of NAD+ and pyruvate 24 . The nicotinamide ring in the L-AlaDH-NAD+ binary complex, obtained by soaking crystals of the apo-enzyme with the nucleotide diphosphate, is however not in a position suitable for hydride transfer from the nicotinamide group to pyruvate. It has therefore been questioned whether this complex represents the catalytically active species 24 .
Here we report the three-dimensional structures of apo-and holo-L-AlaDH from M.
tuberculosis. The structures reveal a conformational transition in the form of a 16° rotation upon binding of the dinucleotide, from an "open" to a "closed" conformation. This conformational change ensures proper orientation of the substrates for hydride transfer to occur and excludes bulk water from the active site. The crystal structures and complementary site-directed mutagenesis studies support a mechanistic model where conformational changes are required to allow access of water and ammonia to the active site, and where the active site residues His96 and Asp270 participate in proton transfer steps during catalysis.
Results and discussion
Subunit structure
The subunit of L-AlaDH is built up of two distinct domains, the substrate binding domain (residues 1-128 and 309-371) and the NAD-binding domain (residues 129-308), connected by two α helices (Figure 2a ). Both domains contain variants of the classical dinucleotide binding fold common to NAD dependent dehydrogenases 29 . The NAD binding domain is characterized by a central seven-stranded mixed β-sheet flanked by α-helices, with one of the edge strands being anti-parallel to the rest of the sheet. The core of the substrate binding domain folds into an eight-stranded β-sheet, containing a six-stranded parallel Rossmann fold, extended by a β-hairpin motif at one side. The two domains are structurally similar to each other (r.m.s.d 2.4 Å, for 82 equivalent Cα atoms), although there is no detectable sequence similarity. The domains are packed such that the C-terminal ends of the β-sheets face each other across a cleft that contains the active site (Figure 2a ). Residues from both domains thus contribute to active site topology and also provide catalytic groups.
Quaternary structure
Gel filtration experiments suggested that MtAlaDH forms a hexamer in solution. The structure of MtAlaDH has been determined in three different crystal forms (Table 1) , which all contain a hexameric molecule, consistent with the solution data. In crystal form P2 1 2 1 2 the asymmetric unit contains a hexamer of 32 symmetry, with a three-fold non-crystallographic axis coinciding with the molecular three-fold axis. In space groups P321 and P2 1 3, which both contain a dimer in the asymmetric unit the hexamer is generated by crystallographic three-fold axes. The quaternary structure is best described as a trimer of dimers (Figure 2b & c) , with the core of the molecule formed by the six NAD binding domains, and the substrate binding domains located at the apical positions of the hexamer (Figure 2c ). This packing of the subunits in the hexamer generates two major interfaces, the 'dimer' interface between two subunits from the upper and lower layers of the hexamer, and the 'trimer' interface between adjacent 'dimers' in the hexamer.
The 'dimer interface' formed by the NAD domains (Figure 2b ) includes the most extensive interactions and is responsible for the AlaDH dimer being the building block of the hexamer.
This interface region is located far from the active site ( Figure 2b ) and buries a surface of more than 1700 Å 2 . Most of the interactions between residues involved in this interface are hydrophobic, but include one salt bridge and ten hydrogen bonds.
The 'trimer interface' is smaller and buries about 1100 Å 2 , with the majority of the interactions almost exclusively between the NAD domains from adjacent dimers. These Table 1 ).
The major structural difference between apo-and holo-MtAlaDH is a shift in the relative orientation of the two domains upon binding of NADH ( Figure 4 ). This conformational 
NAD binding
In the electron density maps of the holo-enzyme, well-defined electron density at the expected dinucleotide binding site was observed that allowed a straightforward fit of NADH to the electron density ( Figure 3c ). The dinucleotide is bound in an extended conformation, with the ribose sugar rings in C2' endo conformation. As in other enzymes of the NAD dehydrogenase family, the dinucleotide is bound to MtAlaDH at the C-terminal end of the β-sheet, with the diphosphate group positioned at the cross-over connection between strands β3 and β4 The side chain of the corresponding aspartic acid residue in PlAlaDH (Asp269) points away from the ribose moiety into the solvent.
Structure of a ternary complex of MtAlaDH with NAD+ and pyruvate
In attempts to obtain structural information on ternary complexes of the enzyme with substrates, co-crystallisation experiments of MtAlaDH as abortive ternary complexes with NADH/alanine and NAD+/pyruvate/NH 3 were carried out. While the combination enzyme-NADH-alanine was unsuccessful, crystals obtained in the presence of 10 mM NAD+, 10 mM NH 3 and 30 mM pyruvate were similar in shape to those of the holo-enzyme, but did not diffract X-rays. However, MtAlaDH co-crystallized with lower concentrations of the substrates (0.5 mM NAD+, 10 mM NH 3 , and 5 mM pyruvate) gave orthorhombic crystals (space group P2 1 2 1 2) that diffracted to 2 Å resolution. These crystals also contain a mixed hexamer with two closed and four open subunits in the asymmetric unit, as described above, and only the subunits in the closed conformation contain bound ligands.
The electron density for the bound NAD+ is well defined. 
Site-directed mutagenesis
The crystal structures described here identified the conserved residues His96 and Asp270 as putative catalytic groups and the function of these groups in catalysis was therefore probed by site-directed mutagenesis ( Table 2 ). Replacement of Asp270 by alanine or asparagine, respectively, resulted in completely inactive mutants that did not allow a more detailed kinetic analysis. The comparison of the crystal structures of the Asp270Asn mutant and wild-type
MtAlaDH showed that the bifurcated hydrogen bond between Asp270 and the ribose of NAD is replaced by a single hydrogen bond. There are no other differences in the positions of active site residues or the bound co-substrate NADH, thus excluding structural defects as the major cause for the catalytic deficiency of this mutant. The amino acid replacement at position His96 also resulted in an enzyme variant with no detectable catalytic activity.
Implications for the catalytic mechanism
Based on a detailed kinetic analysis of AlaDH from Bacilllus subtilis it was proposed that the enzymatic reaction follows a predominantly ordered mechanism and proceeds through iminopyruvate and carbinolamine intermediates 26, 27 . The first step in the reductive amination reaction (Figure 1 ) is the binding of NADH, which as shown in this study stabilizes a closed conformation where the substrate-binding domain moved towards the NADH binding domain.
In Several catalytic steps involve proton transfer reactions (Figure 1 ). Two conserved residues, His96 and Asp270, are suitably positioned at a distance of 3 Å to the pyruvate carbonyl oxygen atom, and therefore are potential acid/base catalysts in the reaction. To further investigate the role of these residues in catalysis Asp270 was exchanged to alanine and asparagine, and His96 to alanine, respectively, by site-directed mutagenesis. Amino acid replacements at these positions led to completely inactive mutant enzymes, and the mutagenesis data thus support critical roles of these conserved residues, possibly as acid/bases in catalysis by MtAlaDH. It is at present, however, not yet clear whether these two residues act in concert (i.e. as a proton relay system) for both proton transfer steps, or if they participate individually at different stages of catalysis, for instance that Asp270 protonates the water molecule after nucleophilic attack and His96 abstracts a proton from the amino group of the carbinolamine or vice versa (Figure 1 ).
In conclusion, the structure analysis of apo-and holo-alanine dehydrogenase from Mt tuberculosis has revealed two conformations of the enzyme. The conformation observed in the presence of the coenzymes NAD+ and NADH, respectively, is characterized by (i) domain closure leading to an active site inaccessible to solvent molecules and favourable for hydride transfer and (ii) completion of the active site by approach of conserved residues that interact with the substrate and participate in catalysis. Furthermore, the closed conformation ensures proper orientation of the nicotinamide ring and the substrate suitable for hydride transfer.
Other steps of the catalytic mechanisms require approach of small nucleophiles such as water and ammonia to the reaction intermediates, which is only possible through conformational changes that make the substrate binding site more accessible.
Methods
Protein production: Wild-type MtAlaDH was produced in E. coli BL21(DE3) containing the Mt ald gene in pET26 (Novagen, UK). The recombinant strain was grown at 30 °C in LBmedium containing 50 µg/mL kanamycin. Induction was performed in mid-log-phase by addition of 1.0 mM IPTG and bacterial cells were harvested 3 hours after induction. The cells were disrupted by sonication, and the crude extract was centrifuged at 20.000 x g for 15 min.
The resulting supernatant was filtered and applied to Ni-NTA resin. Recombinant protein was eluted from the column using an imidazole gradient. The highly purified protein (more than 98% purity as judged by stained SDS-PAGE gels) was stored in 10 mM ammonium bicarbonate buffer, pH 7.7 at 4 °C. respectively, were used for amplification of the two fragments. The template for construction of the mutants was the ald gene without the NdeI restriction site. The purified PCR-products were used in a second round of PCR of five cycles and the resulting two fragments were combined and re-amplified in order to obtain the entire mutated gene. Mutants were verified by DNA analysis. Mutated ald was inserted into NdeI-and HindIII-sites of the expression vector pET26 (Novagen, UK) and the MtAlaDH mutants were produced in E. coli BL21(DE3) and purified as described above.
Site-directed mutagenesis:
Enzyme assays: Specific activities of recombinant MtAlaDH were determined using the assay previously described 17 Crystallization: Crystallization experiments were performed using the vapour-diffusion technique. A protein solution of 6.8 mg/ml MtAlaDH in 10 mM ammonium bicarbonate buffer, pH 8.9 was used throughout the crystallization experiments. Initial screening using commercial sparse matrix crystallization screens gave several hits, which could then be further optimized in 24-well hanging drop plates. Typically, 2 µl aliquots of the protein solution were mixed with 2 µl reservoir solution and set up against 1ml well solution.
Crystals of apo-MtAlaDH were grown using 0. All crystals were flash frozen in liquid nitrogen after transfer for a few seconds into mother liquor containing 30% glycerol. For the soaking experiments the crystals were left for 10 min in mother liquid containing 30% glycerol and 10 mM NADH before flash-freezing.
Data collection and structure determination: All data were collected in a nitrogen stream at 110 K using synchrotron radiation at MaxLab, Lund, Sweden and at the ESRF, Grenoble,
France. Images were processed with the program MOSFLM and scaled using the program SCALA from the CCP4 suite 35 .
The best crystals of the apoenzyme diffracted to 2.3 Å resolution. Initially, the space group P622 was assigned, but inspection of the intensity distribution clearly indicated merohedral twinning. The CCP4 programs Truncate 36 and Detwin 37 in combination with analysis of selfrotation function plots calculated with Molrep 38 were used to further analyze crystal twinning.
The 'Merohedral Crystal Twinning Server' 39 was used for the calculation of the twin fraction.
The twin tests suggested hemihedral twinning, with the true space group being P321 and an estimated twin fraction of 0.3. Molecular replacement was performed using the twinned data and the programm Phaser 40 with PlAlaDH (Pdb code: 1PJC) as search model. Two molecules per asymmetric unit were found. The structure of apo MtAlaDH was refined to 2.3 Å with a fixed twin fraction of 0.3 using the protocol for data with hemihedral twinning in CNS 41 . A test set was excluded to monitor the R free . Care was taken not to bias the refinement and twin- The substrate domains of these two subunits were then manually placed in the electron density, followed by rigid body refinement with the individual domains as separate rigid bodies. After rigid body refinement NADH was manually fitted in the residual electron density using the program Coot 42 .
The crystals obtained in the presence of 10 mM NADH belong to the cubic space group P2 1 3 with one dimer in the asymmetric unit. The structure was phased using the refined closed monomer of MtAlaDH (NADH excluded from the model) as search model in Molrep 38 .
Refinement of the structures of the binary and ternary complexes followed similar protocols.
Rounds of refinement with REFMAC5 43 were interspersed with manual model building in
Coot. Atomic displacement parameters were refined in REFMAC by the TLS method 44 , with each domain of the monomers treated as a single TLS group. Bound ligands were placed manually in the electron density and water molecules were added automatically and inspected manually. The NAD molecules bound to the subunits in the closed conformation of the enzyme showed full occupancies, while in some of the subunits in the open conformation NAD was modelled at occupancies of 0.5.
Refinement of the MtAlaDH D270N mutant holo-enzyme was performed in a similar way as for the wild-type protein. The structure was determined using the closed holo-enzyme as a search model in Molrep 38 , followed by rounds of refinement with REFMAC5 43 which were interspersed with manual model building in Coot 42 .
The final models were validated with PROCHECK 45 . Structural comparisons were carried out using SSM 46 . All figures visualising protein models were prepared using PyMOL (www.pymol.org). The atomic coordinates and observed structure factor amplitudes of
MtAlaDH have been deposited to the Protein Data Bank, accession codes 2VHY
(apoenzyme), 2VHZ (holoenzyme), 2VHW (holohybrid-enzyme), 2VHX (ternary complex with pyruvate and NAD+) and 2VHV (holo-Asp270Asn mutant). 
